On Strategic Choices Faced by Large Pharmaceutical Laboratories and Their Effect on Innovation Risk Under Fuzzy Conditions

Artificial Intelligence in Medicine - Netherlands
doi 10.1016/j.artmed.2019.101703
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search